Reprogramming Ovarian and Breast Cancer Cells Into Non-Cancerous Cells by Low-Dose Metformin or SN-38 Through FOXO3 Activation

Scientific Reports - United Kingdom
doi 10.1038/srep05810
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Auranofin Displays Anticancer Activity Against Ovarian Cancer Cells Through FOXO3 Activation Independent of P53

International Journal of Oncology
Cancer ResearchOncology
2014English

The Disappeared Cancer Cell by SncRNAs: Application of DDMC Vector/SncRNAs Complex for Transformation of Cancer Cells Into Non-Cancerous Cells

Journal of Nanomedicine & Biotherapeutic Discovery
2018English

Resensitization of Cisplatin Resistance Ovarian Cancer Cells to Cisplatin Through Pretreatment With Low‐dose Fraction Radiation

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

CANCER: Reprogramming Cancer Cells

Science
MultidisciplinaryPhilosophy of ScienceHistory
2004English

Modulation of Macrophage Activation Status by Bisphosphonates and Breast Cancer Cells

Bone Abstracts
2013English

Physical Intimacy of Breast Cancer Cells With Mesenchymal Stem Cells Elicits Trastuzumab Resistance Through SRC Activation

Scientific Reports
Multidisciplinary
2015English

Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells Through Cytokine Networks

Cancer Research
Cancer ResearchOncology
2011English

Metformin Induces FOXO3-dependent Fetal Hemoglobin Production in Human Primary Erythroid Cells

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Immunoselection of Breast and Ovarian Cancer Cells With Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells

Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy